Publication

Assessment of metabolic changes in the striatum of a rat model of parkinsonism: An in vivo 1H MRS study

Related publications (51)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Assessment of metabolic changes in the striatum of a rat model of parkinsonism: An in vivo 1H MRS study

Graph Chatbot

Chat with Graph Search

Impact of Mitofusin 2 in the Nucleus Accumbens on motivated behavior and underlying neurobiological mechanisms

A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions

Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease

Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice

Nano-imaging trace elements at organelle levels in substantia nigra overexpressing alpha-synuclein to model Parkinson's disease

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity

A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity

Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration

Parkin functionally interacts with PGC-1 proportional to to preserve mitochondria and protect dopaminergic neurons

PGC-1 alpha activity in nigral dopamine neurons determines vulnerability to alpha-synuclein